http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1016815-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_178493211e0dd63887cf451f98e10b7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31cc5e185fd137037ed8e4ce6852b51d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 |
| filingDate | 1981-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f5f556a793668fcab37a81a28872f42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afebf7c498f231f552ffb00873e1ae6d |
| publicationDate | 1983-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1016815-A1 |
| titleOfInvention | Method of simulating interliver cholestasis in rats |
| abstract | The method of MODELING OF INTRACTURED CHOLESTASTASIS IN RATS, including the introduction of chemicals, which are used so that, in order to quickly and reliably reproduce signs of the disease, Triton WR 1339 and carbon tetrachloride are used as chemical substances, and Triton WR 1339 is administered intraperitoneally to the rat at a dose of 85-100 mg per 100 g of weight, and carbon tetrachloride is administered intragastrically at a dose of 0.1-0.15 ml per 100 g of weight and the interval between the administration of triton WR 13 3 9 and tetrachloride carbon set equal to 2.5 - 3h. |
| priorityDate | 1981-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.